629 related articles for article (PubMed ID: 18456505)
1. Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.
Kirsch L; Timmermans T; Van Caenegem O; Gurne O; Noirhomme P; Jacquet LM; Latinne D; Poncelet AJ
Eur J Cardiothorac Surg; 2008 Aug; 34(2):268-74; discussion 274. PubMed ID: 18456505
[TBL] [Abstract][Full Text] [Related]
2. Lack of sensitization and equivalent post-transplant outcomes with the Novacor left ventricular assist device.
Baran DA; Gass AL; Galin ID; Zucker MJ; Arroyo LH; Goldstein DJ; Prendergast T; Lubitz S; Courtney MC; Correa R; Chan M; Spielvogel D; Lansman SL
J Heart Lung Transplant; 2005 Nov; 24(11):1886-90. PubMed ID: 16297796
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome and bridge to transplant rate of left ventricular assist device recipient patients: comparison between continuous-flow and pulsatile-flow devices.
Garatti A; Bruschi G; Colombo T; Russo C; Lanfranconi M; Milazzo F; Frigerio M; Vitali E
Eur J Cardiothorac Surg; 2008 Aug; 34(2):275-80; discussion 280. PubMed ID: 18375138
[TBL] [Abstract][Full Text] [Related]
4. Immunologic sensitization in recipients of left ventricular assist devices.
John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
[TBL] [Abstract][Full Text] [Related]
5. Blood transfusions decrease the incidence of acute rejection in cardiac allograft recipients.
Fernández FG; Jaramillo A; Ewald G; Rogers J; Pasque MK; Mohanakumar T; Moazami N
J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S255-61. PubMed ID: 15993782
[TBL] [Abstract][Full Text] [Related]
6. Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes.
Joyce DL; Southard RE; Torre-Amione G; Noon GP; Land GA; Loebe M
J Heart Lung Transplant; 2005 Dec; 24(12):2054-9. PubMed ID: 16364849
[TBL] [Abstract][Full Text] [Related]
7. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.
Drakos SG; Kfoury AG; Long JW; Stringham JC; Fuller TC; Nelson KE; Campbell BK; Gilbert EM; Renlund DG
Ann Thorac Surg; 2006 Sep; 82(3):889-93. PubMed ID: 16928502
[TBL] [Abstract][Full Text] [Related]
8. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
9. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
[TBL] [Abstract][Full Text] [Related]
10. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?
Radovancevic B; Golino A; Vrtovec B; Thomas CD; Radovancevic R; Odegaard P; van Rossem CC; Gaemers SJ; Vaughn WK; Smart FW; Frazier OH
J Heart Lung Transplant; 2005 Jun; 24(6):703-7. PubMed ID: 15949730
[TBL] [Abstract][Full Text] [Related]
11. Does the type of ventricular assisted device influence survival, infection, and rejection rates following heart transplantation?
Shuhaiber J; Hur K; Gibbons R
J Card Surg; 2009; 24(3):250-5. PubMed ID: 19438776
[TBL] [Abstract][Full Text] [Related]
12. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
13. Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients.
Xydas S; Yang JK; Burke EM; Chen JM; Addonizio LJ; Mital SR; Itescu S; Hsu DT; Lamour JM
J Heart Lung Transplant; 2005 Sep; 24(9):1289-96. PubMed ID: 16143247
[TBL] [Abstract][Full Text] [Related]
14. Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation.
Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Zuckermann AO; Wieselthaler GM
J Heart Lung Transplant; 2009 Apr; 28(4):367-72. PubMed ID: 19332264
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD30 levels in recipients undergoing heart transplantation do not predict post-transplant outcome.
Ypsilantis E; Key T; Bradley JA; Morgan CH; Tsui S; Parameshwar J; Taylor CJ
J Heart Lung Transplant; 2009 Nov; 28(11):1206-10. PubMed ID: 19782609
[TBL] [Abstract][Full Text] [Related]
16. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.
Dang NC; Topkara VK; Mercando M; Kay J; Kruger KH; Aboodi MS; Oz MC; Naka Y
J Heart Lung Transplant; 2006 Jan; 25(1):1-6. PubMed ID: 16399523
[TBL] [Abstract][Full Text] [Related]
17. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
[TBL] [Abstract][Full Text] [Related]
18. Early and late rejection and HLA sensitization at the time of heart transplantation in patients bridged with left ventricular assist devices.
Gonzalez-Stawinski GV; Atik FA; McCarthy PM; Roselli EE; Hoercher K; Navia JL; Smedira NG; Starling RC; Young JB; Cook DJ
Transplant Proc; 2005 Mar; 37(2):1349-51. PubMed ID: 15848717
[TBL] [Abstract][Full Text] [Related]
19. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival.
Gonzalez-Stawinski GV; Cook DJ; Chang AS; Banbury MK; Navia JL; Hoercher K; Lober C; Atik FA; Taylor DO; Yamani MH; Young JB; Starling RC; Smedira NG
J Heart Lung Transplant; 2006 Jun; 25(6):613-8. PubMed ID: 16730565
[TBL] [Abstract][Full Text] [Related]
20. Sensitisation and post-transplant course after the implantation of ventricular assist device.
Malickaite R; Rucinskas K; Staneviciene A; Miniauskas S; Maneikiene V; Zuoziene G; Sirvydis V
Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):339-42; discussion 342-3. PubMed ID: 19098066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
